SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-24-056462
Filing Date
2024-05-02
Accepted
2024-05-02 16:57:06
Documents
13

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2413199d1_s3.htm S-3 425102
2 EXHIBIT 4.3 tm2413199d1_ex4-3.htm EX-4.3 344686
3 EXHIBIT 5.1(A) tm2413199d1_ex5-1a.htm EX-5.1(A) 25080
4 EXHIBIT 5.1(B) tm2413199d1_ex5-1b.htm EX-5.1(B) 30175
5 EXHIBIT 23.1 tm2413199d1_ex23-1.htm EX-23.1 2666
6 EX-FILING FEES tm2413199d1_ex-filingfees.htm EX-FILING FEES 51639
7 GRAPHIC tm2413199d1_ex5-1aimg006.jpg GRAPHIC 10475
8 GRAPHIC tm2413199d1_ex5-1bimg001.jpg GRAPHIC 8499
9 GRAPHIC tm2413199d1_s3img001.jpg GRAPHIC 7500
10 GRAPHIC tm2413199d1_s3img002.jpg GRAPHIC 108240
11 GRAPHIC tm2413199d1_s3img003.jpg GRAPHIC 2481
12 GRAPHIC tm2413199d1_s3img004.jpg GRAPHIC 109189
13 GRAPHIC tm2413199d1_s3img005.jpg GRAPHIC 2868
  Complete submission text file 0001104659-24-056462.txt   1225112
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-279077 | Film No.: 24909417
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)